Supernus Pharmaceuticals (SUPN) Tax Provisions (2011 - 2026)
Supernus Pharmaceuticals (SUPN) posted quarterly Tax Provisions of $723000.0 for Q2 2026, up 112.4% year-over-year from $340393.3 in Q2 2025, and down 67.43% on a QoQ basis from $2.2 million in Q4 2025.
Supernus Pharmaceuticals (SUPN) Tax Provisions (2011 - 2026) Analysis & Trends
Supernus Pharmaceuticals has reported Tax Provisions for 13 years, with the latest figure at $723000.0 in Q2 2026.
- Tax Provisions for Q2 2026 came in at $723000.0, up 112.4% year-over-year; the trailing twelve-month figure through Jun 2026 was -$15.7 million (down 189.23% YoY), and the FY2025 annual result was -$10.5 million, down 143.66% from the prior year.
- Tax Provisions declined to $723000.0 in Q2 2026, from $2.2 million in the prior quarter.
- Over five years, Tax Provisions peaked at $25.9 million in Q3 2023 and troughed at -$16.3 million in Q2 2023.
- A 5-year average of $928764.7 and a median of $723000.0 in 2026 frame the typical range for Tax Provisions.
- The widest annual swing landed in 2023, when Tax Provisions sank 565.71%; it then jumped 6048.65% in 2024.
- A 5-year view of Tax Provisions shows it stood at $9.7 million in 2022, then sank by 101.92% to -$185000.0 in 2023, then jumped by 6048.65% to $11.0 million in 2024, then tumbled by 79.83% to $2.2 million in 2025, then tumbled by 67.43% to $723000.0 in 2026.
- Per Business Quant data, the three most recent Tax Provisions figures were $723000.0 in Q2 2026, $2.2 million in Q4 2025, and -$12.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 121.00 Mn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -310.32 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 39.70 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 54.80 Mn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 17.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 2.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Supernus Pharmaceuticals | 2.75 Bn | 2.38 Bn | 185.39 Mn | 723,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 723,000.00 |
| Dec 31, 2025 | 2.19 Mn |
| Sep 30, 2025 | -12.84 Mn |
| Jun 30, 2025 | -5.83 Mn |
| Mar 31, 2025 | 6.00 Mn |
| Dec 31, 2024 | 11.05 Mn |
| Sep 30, 2024 | 6.40 Mn |
| Jun 30, 2024 | 6.40 Mn |
| Mar 31, 2024 | 100,000.00 |
| Dec 31, 2023 | -185,000.00 |
| Sep 30, 2023 | 25.87 Mn |
| Jun 30, 2023 | -16.30 Mn |
| Mar 31, 2023 | -7.93 Mn |
| Dec 31, 2022 | 9.63 Mn |
| Sep 30, 2022 | -2.19 Mn |
| Jun 30, 2022 | 3.46 Mn |
| Mar 31, 2022 | -10.90 Mn |
| Dec 31, 2021 | -391,000.00 |
| Sep 30, 2021 | 7.40 Mn |
| Jun 30, 2021 | 7.51 Mn |